+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sarepta Therapeutics - logo

Sarepta Therapeutics is a biopharmaceutical company that focuses on the development of RNA-based therapeutics for the treatment of rare neuromuscular diseases. The company offers EXONDYS 51, a disease-modifying therapy for the treatment of duchenne muscular dystrophy (DMD). It also develops SRP-4045 and SRP-4053, which are exon skipping clinical product candidates for the treatment of DMD. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts.

From
From
Restenosis Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Restenosis Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • June 2018
  • 99 Pages
From
From
Niemann-Pick Type C Disease - Pipeline Insight, 2021 - Product Thumbnail Image

Niemann-Pick Type C Disease - Pipeline Insight, 2021

  • Clinical Trials
  • September 2021
  • 60 Pages
From
From
From
From
From
Multiple sclerosis - Pipeline Insight, 2022 - Product Thumbnail Image

Multiple sclerosis - Pipeline Insight, 2022

  • Clinical Trials
  • March 2022
  • 150 Pages
From
From
Charcot-Marie-Tooth Disease - Pipeline Insight, 2021 - Product Thumbnail Image

Charcot-Marie-Tooth Disease - Pipeline Insight, 2021

  • Clinical Trials
  • September 2021
  • 60 Pages
From
Loading Indicator